An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203386
Company: RK PHARMA

Products on ANDA 203386

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 203386

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/13/2017	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 203386

MITOMYCIN

INJECTABLE;INJECTION; 40MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	064144	ACCORD HLTHCARE
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	211269	FRESENIUS KABI USA
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	216648	GLAND
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	064117	HIKMA
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	214504	MEITHEAL
MITOMYCIN	MITOMYCIN	40MG/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	203386	RK PHARMA

Top